Csl Ltd has released a press release.
CSL to acquire Novartis influenza vaccine business
Filed with ASX ·
Watch CSL's latest callCSL (ASX:CSL) Q4 2026 Earnings Call · Replay · Aug 18Read the transcript of CSL (ASX:CSL) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Story so far
Earlier from CSL
- Chairman`s Address to Shareholders
- Recombinant Technologies
- Chairmans and MDs address to shareholders
- Announcement of buy-back
- Appointment of Paul Perreault as Executive Director
Later from CSL
- IDELVION(R) (rFIX-FP) - European Commission Approval
- Flucelvax Quadrivalent (Influenza Vaccine) - FDA Approval
- AFSTYLA (rFVIII-Single Chain) FDA approval
- 2016 FY Results Announcements and Analysts Briefing
- FDA Accepts BLA for Hereditary Angioedema Therapy
Follow CSL into a list and get an email when it puts out news.
Follow CSL